Get started
Author

Chao‐Chi Wang

Observed names: Chao-Chi (Ally) Wang, Chao-Chi Wang, Wang, Chao-Chi
Institution: KU Leuven
ORCID: 0000-0003-4266-1600
Observed ORCID: 0000-0003-4266-1600
OpenAlex ID: A5038935271
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates
2023 · Patrick Schöffski, Chao-Chi Wang, et al. · Oncology Research and Treatment · 24
Synthesis of CIGS thin film by solvothermal route
2012 · Hsiang-Chen Wang, Chao-Chi Wang, et al. · Optical Materials Express · 21
Synthesis of phenylenevinylene and naphthylenevinylene homopolymers and block copolymers by ring‐opening metathesis polymerization
2017 · Chin‐Yang Yu, Shih‐Hao Wen, et al. · Journal of Polymer Science Part A Polymer Chemistry · 12
Carbazolevinylene and phenylenevinylene polymers by ring-opening metathesis polymerization and their characterization, nanoaggregates and optical and electrochemical properties
2019 · Ching-Ju Liu, Chao-Chi Wang, et al. · Polymer · 7
Patient-derived xenograft models of gastrointestinal stromal tumors provide a ready-to-use platform for translational research
2025 · Luna De Sutter, Lore De Cock, et al. · Disease Models & Mechanisms · 6
PDF
Synthesis, characterization and nanoaggregates of alkyl and triethylene glycol substituted 3,6-carbazolevinylenes homopolymers and block copolymers
2019 · Chao-Chi Wang, Chin-Yang Yu · Polymer · 6
Synthesis and characterization of tetraoctyloxy substituted naphthalenophanedienes
2017 · Chin-Yang Yu, Sheng-Hao Yu, et al. · Tetrahedron Letters · 6
Synthesis, characterization, aggregation-induced emission and nanoaggregates of the copolymers containing different ratios of carbazoles and tetraphenylethylenes
2019 · Yu-Wei Tu, Chao-Chi Wang, et al. · European Polymer Journal · 5
Synthesis and ring opening reaction of octaoctyl substituted [2.2.2.2](2,7)-fluorenophanetetraene by photooxidation
2017 · Chin-Yang Yu, Yu-Chi Chen, et al. · New Journal of Chemistry · 3
Abstract 1880: Ecubectedin and PM54 demonstrate antitumor activity in patient-derived xenograft models of soft tissue sarcoma
2024 · Daniël Gorgels, Agnieszka Wozniak, et al. · Cancer Research · 2
Abstract 1547: The urokinase plasminogen activator receptor-associated protein (uPARAP) is an attractive target for the development of antibody-drug conjugates (ADCs) for treatment of mesenchymal malignancies
2023 · Pernille Barkholt, Agnieszka Wozniak, et al. · Cancer Research · 2
Abstract 5597: Efficacy of novel urokinase plasminogen activator receptor-associated protein targeted antibody-drug conjugates in patient-derived xenografts of soft tissue sarcoma
2025 · Chao-Chi Wang, Agnieszka Wozniak, et al. · Cancer Research · 1
Phosphodiesterase 3A modulators sensitize tumor cells to Bcl-xL and Bcl-2/Bcl-xL inhibitors
2025 · Kirsi Toivanen, Astrid Murumägi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Supplemental Figure 5 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Table 2 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Figure 1 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Figure 2 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Figure 1 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Table 1 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Figure 3 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Table 3 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Figure 3 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Figure 4 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Supplemental Table 1 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Data from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts
2026 · Daniël Gorgels, Chao-Chi Wang, et al.
Works count: 34
Citation count: 95
H-index: 6
I10-index: 3
Year
Topic
Type